State of the Art of Pharmacological Activators of p53 in Ocular Malignancies
Fabio Casciano(University of Ferrara), Angeli Christy Yu(University of Ferrara), Massimo Busin(I.R.C.C.S. Oasi Maria SS), Samar A. Al-Swailem(King Khaled Eye Specialist Hospital), Lorenzo Caruso(University of Ferrara), Enrico Zauli(University of Ferrara), Saleh Al-Mesfer(King Khaled Eye Specialist Hospital), Giorgio Zauli(King Khaled Eye Specialist Hospital)
Cited by 11
Related Papers
Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts
|PLoS ONE|2010|153
An Increased Osteoprotegerin Serum Release Characterizes the Early Onset of Diabetes Mellitus and May Contribute to Endothelial Cell Dysfunction
|American Journal Of Pathology|2006|144
Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3
|Circulation Research|2006|125
Effects of forest walking on physical and mental health in elderly populations: a systematic review
|Reviews on Environmental Health|2022|47